Therapeutic targets in pancreatic cancer

Next Thursday 19th March, Davide Melisi, Instructor Department of Gastrointestinal Medical Oncology, Anderson Cancer Center, University of Texas, will give the next conference at 9:30 am in the Conference room, 2nd floor, Vall d’Hebron Research Institute:

Smad-dependent and Smad-independent pathways in TGF-ß signaling as therapeutic targets in pancreatic cancer

Related Posts